Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302106295.html
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-akebias-anemia-drug-2024-03-28/
https://www.prnewswire.com/news-releases/vafseo-approved-by-the-us-fda-for-the-treatment-of-anemia-due-to-chronic-kidney-disease-in-dialysis-dependent-adult-patients-302102216.html
https://www.prnewswire.com/news-releases/akebia-receives-fda-approval-of-vafseo-vadadustat-tablets-for-the-treatment-of-anemia-due-to-chronic-kidney-disease-in-adult-patients-on-dialysis-302101854.html
https://www.prnewswire.com/news-releases/akebia-therapeutics-reports-fourth-quarter-and-full-year-2023-financial-results-and-recent-business-highlights-302089807.html
https://www.prnewswire.com/news-releases/akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302077525.html
https://www.prnewswire.com/news-releases/akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302052311.html
https://www.prnewswire.com/news-releases/akebia-therapeutics-announces-appointment-of-nicholas-grund-as-chief-commercial-officer-302029322.html
https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302019671.html
https://www.prnewswire.com/news-releases/akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302003603.html